Primary Alcohol-Activated Human and Mouse Hepatic Stellate Cells Share Similarities in Gene-Expression Profiles
Overview
Authors
Affiliations
Alcoholic liver disease (ALD) is a leading cause of cirrhosis in the United States, which is characterized by extensive deposition of extracellular matrix proteins and formation of a fibrous scar. Hepatic stellate cells (HSCs) are the major source of collagen type 1 producing myofibroblasts in ALD fibrosis. However, the mechanism of alcohol-induced activation of human and mouse HSCs is not fully understood. We compared the gene-expression profiles of primary cultured human HSCs (hHSCs) isolated from patients with ALD (n = 3) or without underlying liver disease (n = 4) using RNA-sequencing analysis. Furthermore, the gene-expression profile of ALD hHSCs was compared with that of alcohol-activated mHSCs (isolated from intragastric alcohol-fed mice) or CCl-activated mouse HSCs (mHSCs). Comparative transcriptome analysis revealed that ALD hHSCs, in addition to alcohol-activated and CCl-activated mHSCs, share the expression of common HSC activation ( [collagen type I alpha 1 chain], [actin alpha 1, skeletal muscle], [plasminogen activator inhibitor-1], [tissue inhibitor of metalloproteinase 1], and [lysyl oxidase homolog 2]), indicating that a common mechanism underlies the activation of human and mouse HSCs. Furthermore, alcohol-activated mHSCs most closely recapitulate the gene-expression profile of ALD hHSCs. We identified the genes that are similarly and uniquely up-regulated in primary cultured alcohol-activated hHSCs and freshly isolated mHSCs, which include (macrophage colony-stimulating factor 1 receptor), (pleckstrin), (lysosmal-associated transmembrane protein 5), (class I transactivator, the invariant chain), , (matrix metallopeptidase 9), , (cathepsin S), (TYRO protein tyrosine kinase-binding protein), and (integrin beta-2), and other genes (compared with CCl-activated mHSCs). We identified genes in alcohol-activated mHSCs from intragastric alcohol-fed mice that are largely consistent with the gene-expression profile of primary cultured hHSCs from patients with ALD. These genes are unique to alcohol-induced HSC activation in two species, and therefore may become targets or readout for antifibrotic therapy in experimental models of ALD.
Sun P, Liao S, Sang P, Liu M, Yang J Heliyon. 2024; 10(17):e36705.
PMID: 39281638 PMC: 11401081. DOI: 10.1016/j.heliyon.2024.e36705.
Suzuki H, Iwamoto H, Yamamoto K, Tsukaguchi M, Nakamura T, Masuda A Gastro Hep Adv. 2024; 1(4):555-562.
PMID: 39132059 PMC: 11307517. DOI: 10.1016/j.gastha.2022.02.016.
Rohm T, Castellani Gomes Dos Reis F, Isaac R, Murphy C, Cunha E Rocha K, Bandyopadhyay G Nat Metab. 2024; 6(5):880-898.
PMID: 38605183 PMC: 11430498. DOI: 10.1038/s42255-024-01023-w.
Alcohol-associated liver disease.
Mackowiak B, Fu Y, Maccioni L, Gao B J Clin Invest. 2024; 134(3).
PMID: 38299591 PMC: 10836812. DOI: 10.1172/JCI176345.
Toll-like receptor 5 tunes hepatic and pancreatic stellate cells activation.
Di Fazio P, Mielke S, Bohm I, Buchholz M, Matrood S, Schuppan D BMJ Open Gastroenterol. 2023; 10(1).
PMID: 37433685 PMC: 10347502. DOI: 10.1136/bmjgast-2023-001148.